Novel biotechnological approaches in pharmacology

A.A. 2019/2020
Insegnamento per
2
Crediti
16
Ore totali
Periodo
Gennaio
Lingua
Inglese
Part 1: The course will be focused on the latest acquisitions in the field of the two major psychiatric disorders, depression and schizophrenia. This will include: - Description of the key etiopathological factors for these disorders and how their characterization is important at diagnostic and therapeutic level.
- Description of the available pharmacological treatment and how the understanding of the mechanism of action may eventually lead to the development of novel therapeutic strategies. Part 2: The course will focus on the discussion of experimental and clinical pharmacology of biologics for cardiovascular diseases. This will include:
- New acquisition into the molecular mechanisms governing lipids and lipoprotein metabolism and the role on the inflammatory response.
- Clinical Pharmacology of novel lipid lowering therapies, including monoclonal antibodies and gene silencing approaches and of anti-inflammatory therapies for atherosclerosis.
Non definiti
Modalità di valutazione
Giudizio di approvazione
Giudizio di valutazione
superato/non superato
Docente/i
Ricevimento:
su appuntamento
Dipartimento di Scienze Farmacologiche e Biomolecolari
Ricevimento:
Via Balzaretti 9 - 20133 Milano